Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.
Ductal adenocarcinoma is an uncommon variant of prostatic adenocarcinoma with a generally more aggressive clinical course than usual acinar adenocarcinoma. However, the molecular distinction between ductal and acinar adenocarcinomas is not well characterized. The aim of this investigation was to evaluate the relatedness of ductal versus acinar prostatic adenocarcinoma by comparative gene expression profiling. Archived, de-identified, snap frozen tumor tissue from 5 ductal adenocarcinomas, 3 mixed ductal-acinar adenocarcinomas, and 11 acinar adenocarcinomas cases were analyzed. All cases of acinar and ductal adenocarcinomas were matched by Gleason grade. RNA from whole tissue sections of the 5 ductal and 11 acinar adenocarcinomas cases were subjected to gene expression profiling on Affymetrix U133Plus2 microarrays. Independently, laser-capture microdissection was also performed on the three mixed ductal-acinar cases and five pure acinar cases to isolate homogeneous populations of ductal and acinar carcinoma cells from the same tumor. Seven of these laser-capture microdissected samples (three ductal and four acinar cell populations) were similarly analyzed on U133Plus2 arrays. Analysis of data from whole sections of ductal and acinar carcinomas identified only 25 gene transcripts whose expression was significantly and at least two-fold different between ductal and acinar adenocarcinomas. A similar analysis of microdissected cell populations identified 10 transcripts, including the prolactin receptor, with more significant differences in expression of 5- to 27-fold between ductal and acinar adenocarcinomas cells. Overexpression of prolactin receptor protein in ductal versus acinar adenocarcinoma was confirmed by immunohistochemistry in an independent set of tumors. We conclude that ductal and acinar adenocarcinomas of the prostate are strikingly similar at the level of gene expression. However, several of the genes identified in this study, including the prolactin receptor, represent targets for further investigations on the molecular basis for histomorphological and clinical behavioral differences between acinar and ductal adenocarcinomas.
Sanati
Souzan
S
Department of Pathology and Immunology, Division of Anatomic and Molecular Pathology, Washington University School of Medicine, University Medical Center, 660 South Euclid Avenue, St Louis, MO 63110, USA.
Watson
Mark A
MA
Salavaggione
Andrea L
AL
Humphrey
Peter A
PA
D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics*; D018267:Carcinoma, Acinar Cell / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D044584:Carcinoma, Ductal / Q000737:chemistry / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D016000:Cluster Analysis; D020869:Gene Expression Profiling / Q000379:methods; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D042282:Microdissection; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D011237:Predictive Value of Tests; D011468:Prostatectomy; D012333:RNA, Messenger / Q000032:analysis; D011981:Receptors, Prolactin / Q000032:analysis / Q000235:genetics
D014408:Biomarkers, Tumor; D012333:RNA, Messenger; D011981:Receptors, Prolactin